3 Results for "

human urinary bladder smooth muscle

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "human urinary bladder smooth muscle" in MCE Product Catalog:

Cat. No.: HY-B0549A
CAS No.: 3717-88-2
Synonyms: Rec-7-0040; DW61
Flavoxate hydrochloride (Rec-7-0040; DW61) is an orally active L-type Ca 2+ channel inhibitor and antispasmodic. Flavoxate hydrochloride inhibits cyclic adenosine monophosphate production by blocking voltage-dependent inward Ba 2+ currents, regulating the brainstem micturition center, and stimulating G protein-coupled receptors. Consequently, Flavoxate hydrochloride induces relaxation of bladder smooth muscle and inhibits isovolumetric rhythmic contractions. Flavoxate hydrochloride effectively increases bladder capacity and alleviates symptoms of urgent urination frequency and pollakiuria caused by overactive bladder. Flavoxate hydrochloride can be used in research on overactive bladder and related voiding dysfunctions .
loading...
    loading...
Cat. No.: HY-14825A
CAS No.: 1159101-48-0
Purity:  99.86%
Synonyms: SVT-40776 D-tartrate
Target:  

mAChR

Research Areas:  

Inflammation/Immunology

Tarafenacin (SVT-40776) D-tartrate is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin D-tartrate does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin D-tartrate can be used in the research of overactive bladder .
loading...
    loading...
Cat. No.: HY-14825
CAS No.: 385367-47-5
Synonyms: SVT-40776
Target:  

mAChR

Research Areas:  

Inflammation/Immunology

Tarafenacin (SVT-40776) is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin can be used in the research of overactive bladder .
loading...
    loading...